PORTAGE ANNOUNCES SHARE CONSOLIDATION (REVERSE SPLIT) EFFECTIVE DATE Press ReleaseBy Portage Biotech, IncJune 3, 2020...
Portage is pleased to announce the appointment of Allan L. Shaw as CFO Press ReleaseBy Portage Biotech, IncMay 12, 2020...
PORTAGE MAKES ADDITIONAL INVESTMENT IN STIMUNITY S.A.S, A PARIS-BASED CANCER IMMUNOTHERAPY COMPANY. Press ReleaseBy Portage Biotech, IncMay 11, 2020...
Portage makes an additional investment in Saugatuck therapeutics after achieving proof of concept Press ReleaseBy Portage Biotech, IncMay 5, 2020...
PORTAGE ANNOUNCES CEASE TRADE ORDER REVOKED; UPDATE ON IMPACT OF COVID-19 ON OPERATIONS Press ReleaseBy Portage Biotech, IncApril 16, 2020...
Portage provides update on portfolio company, Intensity Therapeutics, Inc. Press ReleaseBy Portage Biotech, IncApril 15, 2020...
PORTAGE ANNOUNCES FILING OF 3RD QUARTER FINANCIAL STATEMENTS AND PROVIDES UPDATE ON CTO REVOCATION APPLICATION AND OTC TRADING Press ReleaseBy Portage Biotech, IncMarch 13, 2020...
PORTAGE ANNOUNCES FURTHER SUBSCRIPTION OF US$950,000 IN CONVERTIBLE LOAN NOTES TO IOX THERAPEUTICS AND PROVIDES UPDATE ON CTO REVOCATION APPLICATION Press ReleaseBy Portage Biotech, IncJanuary 30, 2020...